Opportunity Information: Apply for RFA GH 14 002

  • The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Addressing Emerging Infectious Diseases in Bangladesh" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
  • This funding opportunity was created on Mar 13, 2014 and posted on Jan 7, 2014.
  • Applicants must submit their applications by Mar 14, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $30,000,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $7,500,000.00 in funding.
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
  • Eligible Organizations Foreign Organizations a Foreign Organization is a public or private organization, whether non profit or for profit, located in a country other than the United States (U.S.) and its territories that is subject to the laws of the country in which it is located, irrespective of the citizenship of project staff or place of performance. Foreign Organizations are eligible to apply. Foreign components of U.S. Organizations are not eligible to apply.
Apply for RFA GH 14 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The grant opportunity titled "Addressing Emerging Infectious Diseases in Bangladesh" (Funding Opportunity Number RFA-GH-14-002) is a Centers for Disease Control and Prevention (CDC) discretionary funding announcement designed to strengthen Bangladesh's ability to detect, study, and respond to diseases that pose significant public health risks. It focuses on supporting field and laboratory research that improves understanding of how important infectious diseases emerge, spread, and can be controlled in real-world settings, with particular attention to threats that can escalate quickly or cross borders.

A central theme of the opportunity is research on emerging and re-emerging infectious diseases. The scope specifically highlights respiratory diseases, zoonotic diseases (infections that spread between animals and people), vector-borne diseases (transmitted by mosquitoes, ticks, or other vectors), and neglected tropical diseases, while also allowing room to address other public health priorities identified within Bangladesh. The intent is not only to generate scientific findings, but to ensure those findings translate into practical public health action. In other words, the work is expected to connect research outputs directly to prevention and control efforts, rather than ending at publication or surveillance summaries.

Another major expectation is applied impact: recipients are meant to incorporate research results into disease prevention and control programs, risk communication materials, and training or capacity-building initiatives. This means the award is oriented toward strengthening systems and workforce skills alongside producing data. Projects under this cooperative agreement would typically be expected to feed evidence into guidance, public messaging, protocols, and training activities that improve readiness and response, especially for outbreaks and high-consequence infectious threats.

The announcement also places clear emphasis on collaboration and knowledge-sharing beyond Bangladesh. Applicants are expected to share expertise and research findings with other nations, agencies, and academic or research institutions. This highlights a broader goal of contributing to regional and global health security by ensuring that methods, lessons learned, and evidence can be used by partners elsewhere, not kept siloed within a single program or country context.

In terms of award structure and funding details, the CDC planned to make one award under a cooperative agreement mechanism, indicating substantial involvement or partnership with the CDC during implementation compared to a more hands-off grant. The estimated total funding for the opportunity is USD 30,000,000, with an award ceiling of USD 7,500,000 and no stated award floor. No cost sharing or matching is required, lowering the barrier for eligible organizations that may not have large amounts of unrestricted funds to contribute.

Eligibility is geared toward foreign organizations. Specifically, public or private entities (non-profit or for-profit) located outside the United States and its territories are eligible as long as they are subject to the laws of the country where they are established, regardless of the citizenship of staff or where activities take place. However, foreign components of U.S. organizations are explicitly not eligible to apply, which signals that this funding stream is intended to support non-U.S.-based institutional leadership rather than overseas branches of U.S. entities.

Key administrative details include the posting date of January 7, 2014, with a closing date of March 14, 2014, and an archive date of April 13, 2014, indicating the opportunity is historical and no longer open. The CFDA number associated with the program is 93.283 (CDC Investigations and Technical Assistance). For access issues related to the full announcement, the contact listed is the CDC Procurement and Grants Office (770-488-2700, PGO TIMS).

Overall, this opportunity is best understood as a large, focused investment aimed at generating actionable infectious disease evidence in Bangladesh and turning that evidence into stronger prevention, response, communication, and training systems, while also contributing knowledge and expertise to wider public health networks internationally.

FAQs: Addressing Emerging Infectious Diseases in Bangladesh (RFA-GH-14-002)

What is the title and funding opportunity number for this grant?

The opportunity is titled "Addressing Emerging Infectious Diseases in Bangladesh" and the Funding Opportunity Number is RFA-GH-14-002.

Which U.S. agency is offering this opportunity?

This is a Centers for Disease Control and Prevention (CDC) discretionary funding announcement.

What is the main purpose of this funding opportunity?

The purpose is to strengthen Bangladesh's ability to detect, study, and respond to infectious diseases that pose significant public health risks. The focus is on field and laboratory research that improves understanding of how key infectious diseases emerge, spread, and can be controlled in real-world settings.

What types of diseases are emphasized in the scope?

The scope emphasizes emerging and re-emerging infectious diseases, with specific highlights including:

  • Respiratory diseases
  • Zoonotic diseases (spread between animals and people)
  • Vector-borne diseases (transmitted by mosquitoes, ticks, or other vectors)
  • Neglected tropical diseases

Does the opportunity allow work on other infectious disease priorities beyond the highlighted areas?

Yes. While the announcement highlights particular disease areas, it also allows room to address other public health priorities identified within Bangladesh.

Is this funding intended mainly for surveillance and publications?

No. The intent goes beyond generating scientific findings. The work is expected to connect research outputs directly to prevention and control efforts, rather than stopping at publication or surveillance summaries.

What does "applied impact" mean in the context of this award?

Applied impact means recipients are expected to incorporate research results into practical public health action. The announcement specifically points to integrating results into disease prevention and control programs, risk communication materials, and training or other capacity-building initiatives.

What kinds of real-world outputs are expected from funded projects?

Based on the description, expected outputs include evidence that can be used to strengthen prevention and control programs, improve risk communication (public messaging and materials), and support training and capacity-building that improves readiness and response to outbreaks and high-consequence infectious threats.

Is collaboration and knowledge-sharing outside Bangladesh part of the expectations?

Yes. Applicants are expected to share expertise and research findings with other nations, agencies, and academic or research institutions, supporting broader regional and global health security goals.

What funding mechanism is used for this opportunity?

The CDC planned to make one award under a cooperative agreement mechanism, which indicates substantial CDC involvement or partnership during implementation compared to a more hands-off grant.

How many awards were planned?

The CDC planned to make one award.

What is the estimated total funding amount for this opportunity?

The estimated total funding is USD 30,000,000.

What is the award ceiling?

The award ceiling is USD 7,500,000.

Is there an award floor (minimum award amount)?

No award floor is stated in the provided information.

Is cost sharing or matching required?

No. The announcement states that no cost sharing or matching is required.

Who is eligible to apply?

Eligibility is geared toward foreign organizations. Public or private entities (non-profit or for-profit) located outside the United States and its territories are eligible as long as they are subject to the laws of the country where they are established, regardless of staff citizenship or where activities take place.

Are foreign components of U.S. organizations eligible?

No. Foreign components of U.S. organizations are explicitly not eligible to apply.

Does the citizenship of project staff affect eligibility?

No. The eligibility description indicates eligibility applies regardless of the citizenship of staff.

Do project activities have to take place in Bangladesh to be eligible?

The eligibility language indicates eligibility is not determined by where activities take place. However, the opportunity purpose and scope are centered on strengthening Bangladesh's ability to detect, study, and respond to infectious diseases.

When was this opportunity posted?

The posting date is January 7, 2014.

What was the application closing date?

The closing date was March 14, 2014.

Is this funding opportunity still open?

No. The archive date is April 13, 2014, and the dates provided indicate the opportunity is historical and no longer open.

What CFDA number is associated with this program?

The CFDA number associated with the program is 93.283 (CDC Investigations and Technical Assistance).

Who is the contact for access issues related to the full announcement?

The contact listed for access issues is the CDC Procurement and Grants Office (PGO TIMS) at 770-488-2700.

What is the overall takeaway of what this grant was trying to achieve?

It was described as a large, focused investment aimed at generating actionable infectious disease evidence in Bangladesh and translating that evidence into stronger prevention, response, communication, and training systems, while also sharing knowledge and expertise with broader public health networks internationally.

Browse more business programs for Infectious Disease Research

Browse more opportunities from the same agency: Centers for Disease Control and Prevention

Browse more opportunities from the same category: Health

Next opportunity: Folded Non Natural Polymers with Biological Function (Fold F(x))

Previous opportunity: Support for Electoral Reforms Project

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA GH 14 002

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA GH 14 002) also looked into and applied for these:

Funding Opportunity
Strengthening Public Health Capacity in Bangladesh Apply for CDC RFA GH14 1405

Funding Number: CDC RFA GH14 1405
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $5,000,000
Saving Lives at Birth A Grand Challenge for Development (Round 4) Apply for RFA OAA 14 000071

Funding Number: RFA OAA 14 000071
Agency: Agency for International Development
Category: Health
Funding Amount: Case Dependent
Service Area Competition Additional Area (SAC AA) Cincinnati, Ohio Apply for HRSA 14 115

Funding Number: HRSA 14 115
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Limited Competition Specific pathogen free macaque colonies (U42) Apply for PAR 14 066

Funding Number: PAR 14 066
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Traumatic Brain Injury State Implementation Partnership Grant Program Apply for HRSA 14 019

Funding Number: HRSA 14 019
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
System level Workforce Capacity Building for Integrating HIV Primary Care in Community Health Care Settings Demonstration Sites Apply for HRSA 14 055

Funding Number: HRSA 14 055
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
System level Workforce Capacity Building for Integrating HIV Primary Care in Community Healthcare Settings Evaluation and Technical Assistance Center Cooperative Agreement Apply for HRSA 14 058

Funding Number: HRSA 14 058
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $550,000
Neurobiology of Migraine (R01) Apply for PA 14 068

Funding Number: PA 14 068
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Neurobiology of Migraine (R21) Apply for PA 14 069

Funding Number: PA 14 069
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
State Public Health Approaches to Improving Arthritis Outcomes Apply for CDC RFA DP12 121003CONT14

Funding Number: CDC RFA DP12 121003CONT14
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
NIA Limited Competition Renewal of, and Revisions to, the Alzheimers Disease Genetics Consortium (U01) Apply for PAR 14 070

Funding Number: PAR 14 070
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
HIV Early Intervention Services (EIS Program) Existing Geographic Service Areas (EISEGA) Apply for HRSA 14 117

Funding Number: HRSA 14 117
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Resource and Technical Assistance Center for HIV Prevention and Care for Black Men who Have Sex with Men (Black MSM) Cooperative Agreement Apply for HRSA 14 106

Funding Number: HRSA 14 106
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $1,500,000
Shared Instrumentation Grant Program (S10) Apply for PAR 14 073

Funding Number: PAR 14 073
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition to Develop a BrainSpan RNA seq Browser (R24) Apply for RFA MH 15 100

Funding Number: RFA MH 15 100
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alzheimers Disease Research Centers (P50) Apply for RFA AG 15 002

Funding Number: RFA AG 15 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Alzheimers Disease Core Centers (P30) Apply for RFA AG 15 001

Funding Number: RFA AG 15 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Poison Center Support and Enhancement Apply for HRSA 14 016

Funding Number: HRSA 14 016
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Supporting Healthy Start Performance Project Apply for HRSA 14 042

Funding Number: HRSA 14 042
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $2,000,000
Service Area Competition Additional Area (SAC AA) DC, FL, GA, ID, IL, KS, MO, MT, NY, OR, PA Apply for HRSA 14 116

Funding Number: HRSA 14 116
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA GH 14 002", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.